Alexander Balck

1.3k total citations
21 papers, 374 citations indexed

About

Alexander Balck is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alexander Balck has authored 21 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 5 papers in Neurology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alexander Balck's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (4 papers) and Neurological diseases and metabolism (3 papers). Alexander Balck is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (4 papers) and Neurological diseases and metabolism (3 papers). Alexander Balck collaborates with scholars based in Germany, United Kingdom and United States. Alexander Balck's co-authors include Christine Klein, Ana Westenberger, Max Borsche, Michael W. Sereda, René Günther, Mathias Bähr, Lars Tönges, Paul Lingor, Jan Christoph Koch and Meike Kasten and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and Science Advances.

In The Last Decade

Alexander Balck

19 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Balck Germany 9 139 104 72 70 64 21 374
Jinze Wu China 9 69 0.5× 104 1.0× 40 0.6× 30 0.4× 22 0.3× 12 310
Nils Schweingruber Germany 8 136 1.0× 75 0.7× 47 0.7× 104 1.5× 22 0.3× 22 435
Raúl Juntas Morales France 10 128 0.9× 271 2.6× 98 1.4× 34 0.5× 27 0.4× 20 522
Thomas Fleetwood Italy 5 120 0.9× 58 0.6× 50 0.7× 41 0.6× 15 0.2× 8 278
Ayobami Ward United States 9 128 0.9× 130 1.3× 48 0.7× 49 0.7× 62 1.0× 17 398
Rhea Choi United States 8 39 0.3× 83 0.8× 37 0.5× 43 0.6× 62 1.0× 13 424
Samia Ben Sassi Tunisia 13 397 2.9× 93 0.9× 109 1.5× 103 1.5× 18 0.3× 41 542
Sue Ling Lim Australia 6 79 0.6× 114 1.1× 32 0.4× 122 1.7× 4 0.1× 6 391
Eleonora Mauri Italy 7 80 0.6× 76 0.7× 50 0.7× 25 0.4× 28 0.4× 22 332

Countries citing papers authored by Alexander Balck

Since Specialization
Citations

This map shows the geographic impact of Alexander Balck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Balck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Balck more than expected).

Fields of papers citing papers by Alexander Balck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Balck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Balck. The network helps show where Alexander Balck may publish in the future.

Co-authorship network of co-authors of Alexander Balck

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Balck. A scholar is included among the top collaborators of Alexander Balck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Balck. Alexander Balck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balck, Alexander, Max Borsche, Philip Campbell, et al.. (2025). The role of dopaminergic medication and specific pathway alterations in idiopathic and PRKN/PINK1 -mediated Parkinson’s disease. Science Advances. 11(20). eadp7063–eadp7063.
2.
Liu, Yanjun, et al.. (2024). Identification of metabolites reproducibly associated with Parkinson’s Disease via meta-analysis and computational modelling. npj Parkinson s Disease. 10(1). 126–126. 10 indexed citations
3.
Schwartz, Brian, Christine Klein, Alexander Katalinic, et al.. (2024). A Vicious Cycle? Group-Level Analysis of Intra-Individual Dynamics in Mental Health Variables. Cognitive Therapy and Research. 49(2). 225–238. 1 indexed citations
4.
Käding, Nadja, Sébastien Boutin, Max Borsche, et al.. (2024). Influence of non-pharmaceutical interventions during the COVID-19 pandemic on respiratory viral infections – a prospective population-based cohort study. Frontiers in Public Health. 12. 1415778–1415778. 6 indexed citations
5.
Kluge, Annika, Max Borsche, Susen Schaake, et al.. (2024). α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification Assay. Annals of Neurology. 95(6). 1173–1177. 15 indexed citations
6.
Föh, Bandik, Maike Schnoor, Alexander Balck, et al.. (2023). Transition to endemic: 2-year SARS-CoV-2 surveillance follow-up of the ELISA cohort. ERJ Open Research. 9(4). 746–2022. 3 indexed citations
7.
Usnich, Tatiana, Björn Hauptmann, Henrike Hanßen, et al.. (2023). Depressive symptoms in Parkinson’s disease are insufficiently but more often treated than in other chronic conditions. npj Parkinson s Disease. 9(1). 113–113. 7 indexed citations
8.
Borsche, Max, Katja Lohmann, Sinem Tunç, et al.. (2023). In Vivo Investigation of Glucose Metabolism in Idiopathic and PRKN‐Related Parkinson's Disease. Movement Disorders. 38(4). 697–702. 8 indexed citations
9.
Balck, Alexander, Bandik Föh, Max Borsche, et al.. (2022). Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study – a prospective population-based cohort study. BMC Public Health. 22(1). 1305–1305. 6 indexed citations
10.
König, Inke R., Meike Kasten, Eva‐Juliane Vollstedt, et al.. (2022). Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson’s disease. Journal of Neurology. 269(8). 4195–4203. 21 indexed citations
11.
Borsche, Max, Johann Rahmöller, Eva‐Juliane Vollstedt, et al.. (2021). Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19. SHILAP Revista de lepidopterología. 3(1). 5 indexed citations
12.
Balck, Alexander, Susen Schaake, Aloysius Domingo, et al.. (2021). Genotype–Phenotype Relations in Primary Familial Brain Calcification: Systematic MDSGene Review. Movement Disorders. 36(11). 2468–2480. 51 indexed citations
13.
Balck, Alexander, Max Borsche, Karen Grütz, et al.. (2020). Don't do harm by diagnosis - An abnormal cranial CT: Still fa(h)r from a disease. Parkinsonism & Related Disorders. 75. 116–118. 2 indexed citations
14.
Föh, Bandik, Max Borsche, Alexander Balck, et al.. (2020). Complications of nasal and pharyngeal swabs: a relevant challenge of the COVID-19 pandemic?. European Respiratory Journal. 57(4). 2004004–2004004. 38 indexed citations
15.
Łukomska, Agnieszka, Alexander Balck, Max Borsche, et al.. (2019). Generation and characterization of human-derived iPSC lines from three pairs of monozygotic twins discordant for Parkinson's disease. Stem Cell Research. 41. 101629–101629.
16.
Westenberger, Ana, Alexander Balck, & Christine Klein. (2019). Primary familial brain calcifications: genetic and clinical update. Current Opinion in Neurology. 32(4). 571–578. 34 indexed citations
17.
Balck, Alexander, Max Borsche, Meike Kasten, et al.. (2019). Discordance in monozygotic Parkinson's disease twins – continuum or dichotomy?. Annals of Clinical and Translational Neurology. 6(6). 1102–1105. 4 indexed citations
18.
Trinh, Joanne, Katja Lohmann, H. Baumann, et al.. (2018). Utility and implications of exome sequencing in early‐onset Parkinson's disease. Movement Disorders. 34(1). 133–137. 27 indexed citations
19.
Günther, René, Alexander Balck, Jan Christoph Koch, et al.. (2017). Rho Kinase Inhibition with Fasudil in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis—Symptomatic Treatment Potential after Disease Onset. Frontiers in Pharmacology. 8. 17–17. 37 indexed citations
20.
Tönges, Lars, René Günther, Martin Suhr, et al.. (2013). Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia. 62(2). 217–232. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinze Wu Breakdown of academic impact, for papers by Nils Schweingruber Breakdown of academic impact, for papers by Raúl Juntas Morales Breakdown of academic impact, for papers by Thomas Fleetwood Breakdown of academic impact, for papers by Ayobami Ward Breakdown of academic impact, for papers by Rhea Choi Breakdown of academic impact, for papers by Samia Ben Sassi Breakdown of academic impact, for papers by Sue Ling Lim Breakdown of academic impact, for papers by Eleonora Mauri
Rankless by CCL
2026